Hemostatic and antithrombotic stewardship programs: A toolkit for program implementation

Hemostatic and antithrombotic agents are high-risk medications associated with high cost. The importance of anticoagulation stewardship has been recently highlighted by national organizations, but hemostatic stewardship programs remain underutilized. Several established hemostatic and/or antithrombotic stewardship programs have demonstrated a significant impact on the quality and cost of care provided to patients receiving these therapies. This review provides a comprehensive toolkit for development and implementation of combined hemostatic and antithrombotic stewardship programs.

Automated summary

Hemostatic and antithrombotic agents are high-risk and high-cost medications, and the importance of anticoagulation stewardship has been emphasized by national organizations. Established hemostatic and/or antithrombotic stewardship programs have shown significant impact on patient care quality and cost. This review provides a comprehensive toolkit for developing and implementing combined hemostatic and antithrombotic stewardship programs.